Citigroup »

Aardvark Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $174k 46k 3.77

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Capital Management
Polygon Management
Geode Capital Management
Adage Capital Partners GP
State Street Corporation
Two Sigma Investments
UBS Group
AQR Capital Management
Millennium Management
Northern Trust
Vanguard Fiduciary Trust

View all funds holding Aardvark Therapeutics